the SmallCapReview mailing list.
Aurinia Pharmaceuticals: A
late-stage biopharmaceutical company providing novel products specifically
engineered to treat a limited, targeted patient population suffering from
serious disease states for which there is a high unmet medical need.
Myriad Genetics: A
personalized medicine company, that focuses on the
development and marketing of predictive, personalized, and
prognostic medicine tests worldwide.
MYGN has a collaboration with AstraZeneca for the
development of an indication for BRACAnalysis CDx.
Where Small Cap Stocks Thrive Since
You Should Be Investing In Russell 2000 Small Cap Index
stocks should be included in any well-diversified portfolio.
Cap Pre Market Movers: ABIL Up 31%, SFET Up 16%, WTER Up 13%
Small Cap Techs On A Roll
Performing Small Caps Of 2018
Cap Indices Show Relative Strength In Both Directions
Your Zip Code Says About You
To Invest In Small Caps
Speed Of Correction In Small Caps
Cap Growth Pics For 2019
Small Caps To Buy In December
Small Caps That Look Like Bargains
Small Caps Set To Explode Higher In 2019
Cap Stocks Can Make Great Stocking Stuffers
Small Caps To Look At Now
For Value Small Caps To Shine
Time To Buy Small Cap Losers Of 18 For Gains In 19
has the potential to become a best in class medication and the first
approved treatment for LN in the U.S. and Europe."
on AUPH here...
has the deepest diagnostic pipeline across the disease spectrum."
on MYGN here...
Subscribers to our Free
newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-up
"A Primer In
is a leading destination for small-cap picks and news. The Purpose of
is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold.
does not give "buy" recommendations, price targets nor
suggest entry and exit points.
"A Look at Small Cap Stocks that may no longer be Small Caps"